Jan. 14 at 10:18 PM
Health Care has been one of the weakest S&P 500 sectors over the past 5 years—but that’s exactly why it’s interesting heading into 2026. Valuations are still below market averages, momentum is improving, and mean reversion may be underway.
$XLV offers clean, low-cost exposure to large-cap health care leaders with modest income.
$BME takes a different approach—active management, monthly distributions, discounts to NAV, and tax-efficient long-term capital gains.
Same sector. Very different tools. Pick based on goals: growth vs income. 🏥📊
#XLV #BME #HealthcareStocks #IncomeInvesting #ClosedEndFunds
https://seekingalpha.com/article/4859754-xlv-vs-bme-total-return-or-income-which-healthcare-strategy-wins